Bladder Cancer Articles and Videos

Dr. Prasad discusses phase 3 ATLAS trial of UGN-102 in non–muscle-invasive bladder cancer

UGN-102 linked with reduced risk of recurrence, progression, or death in LG-IR NMIBC

Dr. Prasad shares the take-home message from the ATLAS study of UGN-102 in LG-IR NMIBC

Comprehensive Urology Care Does Not Mean Sacrificing Community Connection